Clinicopathologic characterization of diffuse-large-B-cell lymphoma with an associated serum monoclonal IgM component.
Recently, diffuse-large-B-cell lymphoma (DLBCL) associated with serum IgM monoclonal component (MC) has been shown to be a very poor prognostic subset although, detailed pathological and molecular data are still lacking. In the present study, the clinicopathological features and survival of IgM-secr...
Main Authors: | M Christina Cox, Arianna Di Napoli, Stefania Scarpino, Gerardo Salerno, Caterina Tatarelli, Caterina Talerico, Mariangela Lombardi, Bruno Monarca, Sergio Amadori, Luigi Ruco |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3976325?pdf=render |
Similar Items
-
Monoclonal antibodies to human IgM
by: Agus Sjahrurachman, et al.
Published: (1999-10-01) -
Acquired von Willebrand Syndrome in IgM Monoclonal Gammopathy as the Presentation of Lymphoplasmacytic Lymphoma
by: Zachary Wolfe, et al.
Published: (2017-01-01) -
Membranous Nephropathy With Monoclonal IgM Lambda Deposits in a Patient With IgM Monoclonal Gammopathy: A Case Report
by: Go Hirose, et al.
Published: (2021-05-01) -
Follicular Lymphoma Presenting With Monoclonal IgM And MYD88 Mutation: A Case Report And Review Of The Literature
by: Xu L, et al.
Published: (2019-09-01) -
Defining an Ultra-Low Risk Group in Asymptomatic IgM Monoclonal Gammopathy
by: David F. Moreno, et al.
Published: (2021-04-01)